Ervebo (rVSV-ZEBOV-GP) vaccine

recombinant vesicular stomatitis virus vaccine expressing Zaire ebolavirus glycoprotein (rVSV-ZEBOV-GP) · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ervebo (rVSV-ZEBOV-GP) vaccine, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure [Phase 2]

See pricing